Institutional members access full text with Ovid®

Label for Simvastatin Revised Again

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing: May 2012 - Volume 112 - Issue 5 - p 23
doi: 10.1097/01.NAJ.0000414313.56707.a3
Drug Watch

* The Food and Drug Administration has reversed its June 2011 decision to reduce the maximum daily dosage of the cholesterol-lowering drug simvastatin (Zocor) when it's coadministered with amiodarone (Cordarone), stating that the agency had reduced the dosage in error; 20 mg is again the maximum dosage.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2012 Lippincott Williams & Wilkins, Inc.